Filtered By:
Infectious Disease: COVID-19
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 5132 results found since Jan 2013.
Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions
CONCLUSIONS: Considering the potentially life-saving benefits of vaccination in a global pandemic environment, it is a safe and effective method to administer vaccines to at-risk patients using desensitization or split dosing techniques, based on their sensitivity status determined through a PEG skin test. This approach allows for the avoidance of preventing access to vaccines, while still ensuring the safety of patients.PMID:37345399 | DOI:10.5578/tt.20239920
Source: Tuberkuloz ve Toraks - June 22, 2023 Category: Respiratory Medicine Authors: Şeyma Özden Fatma Merve Tepetam Özge Atik Source Type: research
Rand Paul Accuses Dr. Fauci of Having ‘Orchestrated’ Cover Up of Covid Origin in Fiery Interview With Bartiromo
Sen. Rand Paul (R-KY) went after the former director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, during a Sunday appearance on Fox News with Maria Bartiromo, accusing the national health expert of covering-up the origins of Covid-19. Throughout the Covid-19…#randpaul #anthonyfauci #mariabartiromo #fauci #wuhan #congressional #niaid #billgates #gates #matttaibbi
Source: Reuters: Health - June 18, 2023 Category: Consumer Health News Source Type: news
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG
Conclusions: The small percentage of people who have extremelevels of anti-PEG Ab in their blood may be at increased risk for HSRs/anaphylaxis to PEGylated vaccines and other PEGylated injectables. This risk might be further increased by the anti-PEG immunogenicity of these vaccines. Screening for anti-PEG Ab "supercarriers" may help predicting reactors and thus preventing these adverse phenomena.PMID:37330369 | DOI:10.1016/j.vaccine.2023.06.009
Source: Vaccine - June 17, 2023 Category: Allergy & Immunology Authors: Gergely Tibor Kozma Tam ás Mészáros Petra Ber ényi R éka Facskó Zs ófia Patkó Csaba Zs Ol áh Adrienne Nagy Tam ás Gyula Fülöp Kathryn Anne Glatter Tam ás Radovits B éla Merkely J ános Szebeni Source Type: research
Controller therapy attenuates asthma exacerbations associated with prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children
Nearly 80% of asthma exacerbations are associated with viral respiratory infections.1 The first cases of coronavirus disease 2019 (COVID-19) because of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in late December 2019 in Wuhan, People's Republic of China, and was first reported in the United States in January 2020.2
Source: Annals of Allergy, Asthma and Immunology - June 12, 2023 Category: Allergy & Immunology Authors: Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant Tags: Letters Source Type: research
Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children
Abbreviations: Coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2), inhaled corticosteroids (ICS), oral corticosteroid (OCS), short-acting beta-agonist (SABA), long-acting beta-agonist (LABA), leukotriene receptor antagonist (LTRA), rate ratios (RR), polymerase chain reaction (PCR)
Source: Annals of Allergy, Asthma and Immunology - June 12, 2023 Category: Allergy & Immunology Authors: Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant Tags: Letters Source Type: research
Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry" by Sparks et al
We read with great interest the Global Rheumatology Alliance report on COVID-19 on biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis (RA).1 The first important result of the registry database is that B-cell depletion, by compromising the primary antibody response, increases the severity of infected patients. Considering the critical role of B cells in the adaptive immune response, this sounds quite correct.2 Even the data on interleukin 6 and tumour necrosis factor (TNF) inhibitors appear quite understandable considering the systemic inflammation raised by SARS-CoV-2 infe...
Source: Annals of the Rheumatic Diseases - June 12, 2023 Category: Rheumatology Authors: Gremese, E., Ferraccioli, G. Tags: ARD, COVID-19 Correspondence Source Type: research
Updated Guidance Regarding The Risk ofAllergic Reactions to COVID-19 Vaccines and Recommended Evaluation and Management: A GRADE Assessment, and International Consensus Approach
J Allergy Clin Immunol. 2023 Jun 7:S0091-6749(23)00746-7. doi: 10.1016/j.jaci.2023.05.019. Online ahead of print.ABSTRACTThis guidance updates 2021 GRADE recomendations regarding immediate allergic reactions following COVID-19 vaccines and addresses re-vaccinating individuals with 1st dose allergic reactions and allergy testing to determine re-vaccination outcomes. Recent meta-analyses assessed the incidence of severe allergic reactions to initial COVID-19 vaccination, risk of mRNA-COVID-19 re-vaccination after an initial reaction, and diagnostic accuracy of COVID-19 vaccine and vaccine excipient testing in predicting reac...
Source: Clinical Lung Cancer - June 9, 2023 Category: Cancer & Oncology Authors: Matthew Greenhawt Timothy E Dribin Elissa M Abrams Marcus Shaker Derek K Chu David Bk Golden Cem Akin Akterini Anagnostou Faisal ALMuhizi Waleed Alqurashi Peter Arkwright James L Baldwin Aleena Banerji Philippe B égin Moshe Ben-Shoshan Jonathan Bernstein Source Type: research
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach
This guidance updates 2021 GRADE (Grading of Recommendations Assessment, Development and Evaluation) recommendations regarding immediate allergic reactions following coronavirus disease 2019 (COVID-19) vaccines and addresses revaccinating individuals with first-dose allergic reactions and allergy testing to determine revaccination outcomes. Recent meta-analyses assessed the incidence of severe allergic reactions to initial COVID-19 vaccination, risk of mRNA-COVID-19 revaccination after an initial reaction, and diagnostic accuracy of COVID-19 vaccine and vaccine excipient testing in predicting reactions.
Source: Journal of Allergy and Clinical Immunology - June 7, 2023 Category: Allergy & Immunology Authors: Matthew Greenhawt, Timothy E. Dribin, Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David B.K. Golden, Cem Akin, Akterini Anagnostou, Faisal ALMuhizi, Waleed Alqurashi, Peter Arkwright, James L. Baldwin, Aleena Banerji, Philippe B égin, Moshe Ben-Shosha Tags: Review article Source Type: research
COVID Nonvaccination Linked With Avoidable Hospitalizations COVID Nonvaccination Linked With Avoidable Hospitalizations
Compared with patients who were vaccinated and boosted, unvaccinated patients with COVID-19 had a 21-fold greater risk for hospitalization, data suggest.Medscape Medical News
Source: Medscape Allergy Headlines - June 1, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
Omega-3 Fatty Acid Supplementation for the Treatment of Persistent COVID-Related Olfactory Dysfunction
CONCLUSION: Among patients with persistent COVID-related OD, our study showed no clear evidence of relative short-term or long-term olfactory recovery among patients receiving high doses of O3FA supplementation.PMID:37261995 | DOI:10.1177/19458924231174799
Source: American Journal of Rhinology and Allergy - June 1, 2023 Category: ENT & OMF Authors: David K Lerner Katherine L Garvey Annie Arrighi-Allisan Evan Kominsky Andrey Filimonov Abdurrahman Al-Awady Peter Filip Katherine Liu Sen Ninan Todd Spock Benjamin Tweel Maaike van Gerwen Madeleine Schaberg Patrick Colley Anthony Del Signore Satish Govind Source Type: research
